Yes, You Read That Right. Palantir Just Won $10 Billion From the U.S. Army.

Palantir Technologies secured a $10 billion, 10-year U.S. Army contract, consolidating 75 existing agreements into a single award worth approximately $1 billion annually. While this deal primarily bundles pre-existing work rather than generating significant new revenue, it represents a substantial portion of Palantir's trailing 12-month revenue and is expected to enhance profit margins by eliminating contract-related fees. However, despite this large government commitment, the article concludes that Palantir's stock remains highly overvalued, trading at extreme multiples relative to its current earnings and projected growth, suggesting it may not be a compelling investment at its current price.

Analysis

Palantir Technologies has secured a significant $10 billion, 10-year contract from the U.S. Army, which consolidates 75 existing smaller contracts into a single enterprise agreement. While the headline figure is substantial, the contract primarily formalizes and secures an existing revenue stream of approximately $1 billion annually, rather than introducing a large tranche of new business. This annual figure represents a material 29% of Palantir's $3.4 billion in trailing-twelve-month revenue. A key positive catalyst from this deal is the potential for enhanced profitability; the agreement is structured to remove contract-related fees, which could further boost Palantir's already impressive operating profit margin, which has expanded from 5.4% in 2023 to 23.3% this year. However, this operational strength is juxtaposed with a severe valuation challenge. The stock trades at exceptionally high multiples, including 573 times trailing earnings and 255 times free cash flow. This valuation appears unsustainable when compared against analyst consensus estimates, which project a 40% long-term earnings growth rate, a figure well below the triple-digit growth likely required to justify the current stock price.

Key Decisions for Investors

• Investors should recognize that the $10 billion U.S. Army contract primarily de-risks a substantial portion of future revenue rather than adding significant new growth, though it does present a clear opportunity for margin expansion.
• Given the stock's valuation at 573 times trailing earnings, prospective buyers should exercise extreme caution as the price appears to have fully incorporated, and likely exceeded, the company's strong growth prospects and recent contract wins.
• Monitor Palantir's ability to generate earnings growth well above the consensus 40% forecast, as achieving a growth rate that can justify the current valuation is the most critical factor for the stock's future performance.